Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates

Go back to Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates

Moderna (MRNA) Tops Q1 EPS by 45c

May 6, 2021 7:08 AM EDT

Moderna (NASDAQ: MRNA) reported Q1 EPS of $2.84, $0.45 better than the analyst estimate of $2.39. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $2.44 billion.

2021 Updated Financial Framework

Advance Purchase Agreements (APAs): The Company has already signed APAs for scheduled... More